Table 2.
Chromosomal Instability in Clones Subjected to Chronic Oxidative Stress.
| Treatment | Number of Clones | Number of Metaphase Subpopulations* | Percentage of Metaphases† |
| Controls | 44 | 0–3 | 0–3 |
| H2O2, 100 µm | 31 | 0–2 | 0–5.5 |
| 2 | 1–2 | 97–100 | |
| 6 | 3–4 | 1.5–3.5 | |
| 5 | 3–5 | 5–18 | |
| H2O2, 200 µm | 35 | 0–4 | 0–3.5 |
| 1 | 1 | 61 | |
| 7 | 3–5 | 6.5–10.5 | |
| 3 | 7–10 | 52–75 | |
| GO, 50 mU/ml | 39 | 0–3 | 0–4 |
| 7 | 3–6 | 5–23 | |
| 2 | 7–8 | 21–100 | |
Boldface indicates chromosomally unstable clones, as defined by those clones containing three or more abnormal metaphase subpopulations comprising at least 5% of all metaphases scored.
Number of different abnormal metaphase subpopulations showing distinct types of chromosome aberrations.
Percentage of metaphases scored showing chromosomal aberrations.